Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease

To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female wit...

Descripción completa

Detalles Bibliográficos
Autores principales: CP, Juarez, AL, Gramajo, JD, Luna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Hypothesis, Discovery & Innovation Ophthalmology 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939753/
https://www.ncbi.nlm.nih.gov/pubmed/24600639
_version_ 1782305737609838592
author CP, Juarez
AL, Gramajo
JD, Luna
author_facet CP, Juarez
AL, Gramajo
JD, Luna
author_sort CP, Juarez
collection PubMed
description To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female with photocoagulation treatment to control the recurrence of vitreous haemorrhage. Our results revealed that stabilization of the disease and improvement in visual acuity were achieved without any signs of recurrence. Intravitreal bevacizumab in combination with photocoagulation treatment of ischemic retinal areas may be a good alternative for patients with recurrent vitreous haemorrhage due to Eales disease.
format Online
Article
Text
id pubmed-3939753
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medical Hypothesis, Discovery & Innovation Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-39397532014-03-05 Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease CP, Juarez AL, Gramajo JD, Luna Med Hypothesis Discov Innov Ophthalmol Original Research To report the efficacy of combination therapy (bevacizumab and photocoagulation) in a case of Eales Disease this study has been performed. Bevacizumab (Avastin, 1.25 mg/0.05 ml) was injected intravitreously for the treatment of iris and retinal neovascularization in a 56-year old Hispanic female with photocoagulation treatment to control the recurrence of vitreous haemorrhage. Our results revealed that stabilization of the disease and improvement in visual acuity were achieved without any signs of recurrence. Intravitreal bevacizumab in combination with photocoagulation treatment of ischemic retinal areas may be a good alternative for patients with recurrent vitreous haemorrhage due to Eales disease. Medical Hypothesis, Discovery & Innovation Ophthalmology 2013 /pmc/articles/PMC3939753/ /pubmed/24600639 Text en © 2013, Medical Hypothesis, Discovery & Innovation (MEHDI) Ophthalmology Journal This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
CP, Juarez
AL, Gramajo
JD, Luna
Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title_full Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title_fullStr Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title_full_unstemmed Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title_short Combination of Intravitreal Bevacizumab and Peripheral Photocoagulation: An Alternative Treatment in Eales Disease
title_sort combination of intravitreal bevacizumab and peripheral photocoagulation: an alternative treatment in eales disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939753/
https://www.ncbi.nlm.nih.gov/pubmed/24600639
work_keys_str_mv AT cpjuarez combinationofintravitrealbevacizumabandperipheralphotocoagulationanalternativetreatmentinealesdisease
AT algramajo combinationofintravitrealbevacizumabandperipheralphotocoagulationanalternativetreatmentinealesdisease
AT jdluna combinationofintravitrealbevacizumabandperipheralphotocoagulationanalternativetreatmentinealesdisease

Ejemplares similares